Early peritoneal dialysis reduces lung inflammation in mice with ischemic acute kidney injury

Kidney Int. 2017 Aug;92(2):365-376. doi: 10.1016/j.kint.2017.01.020. Epub 2017 Mar 16.


Although dialysis has been used in the care of patients with acute kidney injury (AKI) for over 50 years, very little is known about the potential benefits of uremic control on systemic complications of AKI. Since the mortality of AKI requiring renal replacement therapy (RRT) is greater than half in the intensive care unit, a better understanding of the potential of RRT to improve outcomes is urgently needed. Therefore, we sought to develop a technically feasible and reproducible model of RRT in a mouse model of AKI. Models of low- and high-dose peritoneal dialysis (PD) were developed and their effect on AKI, systemic inflammation, and lung injury after ischemic AKI was examined. High-dose PD had no effect on AKI, but effectively cleared serum IL-6, and dramatically reduced lung inflammation, while low-dose PD had no effect on any of these three outcomes. Both models of RRT using PD in AKI in mice reliably lowered urea in a dose-dependent fashion. Thus, use of these models of PD in mice with AKI has great potential to unravel the mechanisms by which RRT may improve the systemic complications that have led to increased mortality in AKI. In light of recent data demonstrating reduced serum IL-6 and improved outcomes with prophylactic PD in children, we believe that our results are highly clinically relevant.

Keywords: acute kidney injury; cytokines; dialysis; uremia.

Publication types

  • Evaluation Study

MeSH terms

  • Acute Kidney Injury / blood
  • Acute Kidney Injury / complications
  • Acute Kidney Injury / therapy*
  • Animals
  • Interleukin-6 / blood
  • Lung Injury / blood
  • Lung Injury / etiology
  • Lung Injury / prevention & control*
  • Mice
  • Models, Animal*
  • Peritoneal Dialysis / instrumentation
  • Peritoneal Dialysis / methods*


  • Interleukin-6
  • interleukin-6, mouse